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Abstract TRPC5 is a member of the canonical transient
receptor potential (TRPC) family of proteins that forms
cationic channels either through homomultimeric assembly
or heteromultimeric coordination with other TRPC proteins.
It is expressed in a variety of cells including central neurones
and endothelial cells and has susceptibility to stimulation by
multiple factors. Here we investigated if TRPC5 is sensitive
to nitric oxide. Mouse TRPC5 or human TRPC5 was over-
expressed in HEK293 cells, and TRPC5 activity was
determined by measuring the cytosolic Ca2+ concentration
with an indicator dye or by recording membrane current
under voltage clamp. TRPC5 activity could be evoked by
carbachol acting at muscarinic receptors, lanthanum, or a
reducing agent. However, S-nitroso-N-acetylpenicillamine
(SNAP) and diethylamine NONOate (DEA-NONOate)
failed to stimulate or inhibit TRPC5 at concentrations that
generated nitric oxide, caused vasorelaxation, or suppressed
activity of TRPC6 via protein kinase G. At high concen-
trations, SNAP (but not DEA-NONOate) occasionally
stimulated TRPC5 but the effect was confounded by
background TRPC5-independent Ca2+ signals. Endogenous
Ca2+-entry in bovine aortic endothelial cells (BAECs) was
suppressed by SNAP; TRPC5 blocking antibody or
dominant-negative mutant TRPC5 suppressed this Ca2+
entry and occluded the effect of SNAP. The data suggest
that nitric oxide is not a direct modulator of homomeric
TRPC5 channels but may inhibit endogenous BAEC
channels that contain TRPC5.
Keywords Transient receptor potential . Nitric oxide .
Nitrovasodilators . Endothelial cell . TRP channels
Introduction
Nitric oxide (NO) is a short-lived, reactive molecule that
serves as an important cellular signal [15]. NO signaling is
involved in endothelial-dependent vascular relaxation, cell
motility, immune defense, and neurite outgrowth [2, 4, 7].
While many NO-elicited responses are mediated by cGMP,
which is produced from the activity of NO-stimulated
guanylate cyclase [15], NO can also act independently of
cGMP [6]. A well-documented NO action independent of
cGMP is S-nitrosylation. In S-nitrosylation, a nitric oxide
moiety is covalently attached to cysteine residues of a
protein, resulting in alteration in protein function. S-
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nitrosylation serves as a type of posttranslational modifica-
tion analogous to phosphorylation and acetylation. While
some substrate proteins are constitutively S-nitrosylated [8],
other proteins can be reversibly S-nitrosylated dependent
upon the concentration of NO and the accessibility of the
NO radicals to the cysteine residues [6]. A wide spectrum
of proteins including metabolic, structural, and signaling
proteins can be S-nitrosylated [6, 8]. S-nitrosylation is
reported to modulate the activity of a number of ion
channels including Ca2+-activated K+ channels, ryanodine
receptors, hyperpolarization-activated cation channels,
cyclic nucleotide-gate channels, and N-methyl-D-aspartate
receptors [6, 8, 16].
TRPC5 is a Ca2+-permeable cationic channel that
modulates properties of mammalian cells including neuro-
nes and endothelial cells [1]. It can form channels on its
own or assembled with other related proteins such as
TRPC1 and TRPC4. Each channel is thought to require four
TRPC proteins to assemble around a central ion pore. The
channels show constitutive activity and voltage dependence
but they are also stimulated by a range of factors including
agonists at G protein-coupled receptors, lysophospholipids,
redox factors, and acidification. In addition, it has been
suggested that the channels are stimulated by NO through a
mechanism that requires direct S-nitrosylation of TRPC5 at
two cysteine residues near the ion pore [24]. The effect was
suggested to be functionally important in endothelial cells,
which have a crucial role in generating NO. However, the
conclusions are difficult to reconcile with data suggesting
that the same cysteine residues form a disulphide bridge
[23] and that NO has commonly been found to be an
inhibitor of Ca2+ entry in endothelial cells [5, 11, 18, 21,
but see 13]. Here, we show data generated independently by
our two laboratories that lead us to conclude that NO is not
a direct modulator of TRPC5.
Materials and methods
Cell culture and cDNA expression
For single-cell Ca2+ imaging studies, mouse TRPC5
(mTRPC5) in pcDNA3 or human TRPC3 (hTRPC3) in
pcDNA6 were stably transfected into HEK293 cells. For
experiments with protein kinase G (PKG) inhibition of
TRPC6, PKG-1α in pcDNA6 and mTRPC6 in pcDNA3
were stably cotransfected into HEK293 cells. mTRPC5 and
mouse TRPC6 clones were gifts from L. Birnbaumer
(NIH). Transfection and cell culture of HEK293 were done
as described elsewhere [12]. Expression of TRPC5 was
validated by western blotting (Suppl. Fig. 1). For the
multiwell fluorescence plate reader system, HEK293 cells
stably expressing tetracycline-inducible human TRPC5
(hTRPC5) was established and cultured as described
previously [25]. The expression of hTRPC5 was induced
by 1 µg/ml tetracycline (Tet+) for 24–48 h before experi-
ments. Noninduced cells without addition of tetracycline
(Tet−) were used as control. The primary cultured bovine
aortic endothelial cells (BAECs) were isolated from bovine
aorta obtained from the local abattoir and using methodol-
ogy described previously [3]. Briefly, aortic segments were
cut open longitudinally. The intima layer was peeled off
and then digested with 0.1% collagenase in phosphate-
buffered saline (PBS; in mM: 140 NaCl, 3 KCl, 25 Tris, pH
7.4) for 15 min at 37°C under vigorous shaking. Dissoci-
ated cells were centrifuged, resuspended, and then grown in
a culture medium RPMI-1640 supplemented with 10% fetal
bovine serum. Cells of passage 3–12 were used for
experiments. In some experiments, BAECs were trans-
fected with pEGFP-N1 or dominant-negative TRPC5
construct (DN-T5) by electroporation (Nucleofector, Lonza
Cologne). Transfected cells were seeded on coverslips and
cultured for 2 days before experiments. DN-T5 was gift
from D. Clapham (Harvard University). All cells were
cultured in 95% air and 5% CO2.
Intracellular Ca2+-measurement
For single-cell Ca2+ imaging studies, intracellular Ca2+
([Ca2+]i) was imaged using the InCyt Basic Im2 live cell
system (Intracellular Imaging). For multiwell intracellular
Ca2+ measurement studies, intracellular Ca2+ was measured
using a fluorescence plate reader system (FlexStation,
Molecular Devices). In single-cell Ca2+ imaging experi-
ments, cells seeded on coverslip were loaded with 5 µM
fura-2 AM in culture medium for 30 min and then
mounted in a recording chamber containing bath solution.
Stock solutions of the chemicals were kept on ice during
the experiment. At approximately 10 s before each
chemical addition, one tenth of the bath solution was
pipetted to dilute the chemical from its stock, before
readdition of the solution to the bath. Normal physiological
saline solution contained, in mM: 140 NaCl, 5 KCl, 2
MgCl2, 1 CaCl2, 10 glucose, 10 Hepes (pH titrated to 7.4
with NaOH). Hepes-buffered saline (HBS) contained in
mM: 107 NaCl, 6 KCl, 1.2 MgSO4, 2 CaCl2, 11.5 glucose,
20 Hepes (pH titrated to 7.4 with NaOH). HBS-EGTA
contained in mM: 107 NaCl, 6 KCl, 1.2 MgSO4, 0.5
EGTA, 11.5 glucose, 20 Hepes (pH titrated to 7.4 with
NaOH). For FlexStation experiments, cells were plated in
96-well biocoat plates (Corning) to 80–90% confluence 24–
48 h before experiments. Prior to recording, cells were
incubated for 1 h at 37°C in standard bath solution (SBS)
containing 2 µM fura-2 AM and (in mM) 130 NaCl, 5 KCl,
8 glucose, 10 Hepes, 1.2 MgCl2, and 1.5 CaCl2 (pH titrated
to 7.4 with NaOH). Subsequently, the cells were washed
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with fresh SBS for 0.5 h at room temperature. Fura-2 was
excited by light at 340 and 380 nm and emission was
filtered at 510 nm. Experiments were at room temperature
(∼23°C). Most experiments were performed using fura-2 as
the fluorescent dye, where the [Ca2+]i response was
expressed as the ratio of the fluorescence signal from
excitation at 340 nm to that at 380 nm (F340/380). Some
experiments were done using fluo-3 as the fluorescent dye,
where the [Ca2+]i response was expressed as real-time fluo-
3 fluorescence relative to its initial value before application
of chemicals (Ft/F0). In FlexStation experiments, NO
donors were diluted in bath solution to five times the final
concentration immediately before each experiment and
applied to cells at five times dilution by the FlexStation
within 5 (column 1) and 30 min (column 2); no difference
between data from columns 1 and 2 was observed.
Electrophysiology
To study hTRPC5, whole-cell patch-clamp recordings were
performed as described previously [23]. Patch pipette
solution contained (in mM): 115 CsCl, 10 EGTA, 2 MgCl2,
5 Na2ATP, 0.1 NaGTP, 10 Hepes, 5.7 CaCl2 (osmolarity
was adjusted to ∼290 mOsm with mannitol and pH was
titrated to 7.2 using CsOH). The extracellular (bath)
solution was SBS. A salt–agar bridge was used to connect
the Ag–AgCl ground wire to the bath. Signals were
amplified with an Axopatch 200B patch-clamp amplifier
and controlled with Signal software 3.05 (CED). A 1-s
ramp protocol from −100 mV to +100 mV was applied at a
frequency of 0.1 Hz from a holding potential of −60 mV.
Current signals were analogue filtered (Bessel) at 1 kHz
and digitally sampled at 3 kHz. NO donors were prepared
freshly for each experiment within 1–2 min before
application.
Isometric tension measurement
Segments of mouse aorta ∼2 mm in length were dissected
from ∼5-week-old male C57BL/6 mice and the endothelial
layer was rubbed off. The segments were mounted in a wire
myograph (610 M, Danish Myograph Technology) under a
normalized tension as previously described [3]. The aortic
segments were preconstricted with 10 µM phenylephrine to
achieve sustained contractions. Approximately 30 min
before phenylephrine-induced precontraction, dimethyl
sulfoxide (DMSO)-diluted NO donors were prepared from
stocks into the following concentrations (in mM): 0.1, 0.3,
1, and 300 for SNAP; 0.01, 0.1, 1, 10, and 100 for
diethylamine NONOate (DEA-NONOate). The diluted NO
donors were kept on ice and used for a single set of
experimental recordings. The NO donors were added in a
cumulative fashion to the bath solution, which was Krebs
solution containing, in mM: 118 NaCl, 4.7 KCl, 2.5 CaCl2,
1.2 MgSO4, 1.2 KH2PO4, 25.2 NaHCO3, and 11.1 glucose,
gassed with 95% O2–5% CO2. Experiments were per-
formed at 37°C. Data were acquired and analyzed using
PowerLab and LabChart (AD Instruments).
Measurement of NO release using multiwell imaging
system
HEK293 cells cultured in 96-well plates were loaded with
10 µM DAF-FM acetate (Invitrogen, UK) by incubating at
room temperature for 45 min. Cells were washed for 20 min
and fluorescence emission at 520 nm was measured with
excitation at 495 nm by the multiwell fluorescence plate
reader system (FlexStation, Molecular Devices). Fluores-
cence values were divided by 1,000 and indicated as F*.
Immunoblotting
Whole-cell lysates were extracted with detergent extraction
buffer, which contained 1% (v/v) Nonidet P-40, 150 mM
NaCl, 20 mM Tris–HCl, pH 8.0, or NuPAGE LDS buffer
(Invitrogen) with addition of protease inhibitor cocktail
tablets. Equal quantities of extracted proteins were applied
to each lane and separated on SDS/PAGE gel. The proteins
were then blotted onto a PVDF/nitrocellulose membrane.
The membrane was incubated at 4°C overnight with anti-
TRPC5 or anti-TRPC6 antibody (dilution 1:200 for
Alomone Lab anti-TRPC5 and anti-TRPC6, or dilution
1:500 for custom made T5C3 to peptide CKLLDSSEDV
FETWGE) in PBS solution (Invitrogen) containing 0.1%
Tween 20 and 5% nonfat dry milk. The membrane was
washed in PBS + Tween 20 (0.1%) and incubated with
horseradish-conjugated secondary antibodies for 1 h.
Immunodetection was accomplished by ECL detection
system and X-ray film exposure. Immunoblots with anti-
β-tubulin antibody or anti-β-actin (Santa Cruz Biotechnol-
ogy) were used to confirm that an equal amount of proteins
was loaded onto each lane.
Immunodetection of TRPC5 in BAECs
Immunocytochemical staining of BAECs was done as
described previously, with slight modifications [20]. The
fixed cells were incubated with or without primary anti-
bodies of rabbit anti-TRPC5 (dilution 1:100, Alomone Lab)
and goat antiplatelet endothelial cell adhesion molecule 1
(anti-PECAM1, dilution 1:100, Santa Cruz) at 4°C over-
night, followed by incubation with secondary donkey anti-
rabbit IgG conjugated to Alexa Fluor 488 (1:200) and
donkey anti-goat IgG conjugated to Alexa Fluor 546
(1:200). Immunofluorescence was detected by FV1000
confocal system (Olympus). Fluorescence signals were
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acquired at the settings under which the signals from the
control cells (without primary antibodies) were absent.
Anti-TRPC5 blocking antibody
Anti-TRPC5-blocking antibody (T5E3) was raised in
rabbits by replicating a previously described strategy [22].
Briefly, a peptide corresponding to TRPC5 putative pore
region (CYETRAIDEPNNCKG) was synthesized and
conjugated to keyhole limpet hemocyanin at Alpha Diag-
nostic International. The conjugated T5E3 peptide was
injected subcutaneously to the back of a rabbit followed by
two booster doses. T5E3 antiserum was collected 4 weeks
after the second booster. IgG was purified from T5E3
antiserum and preimmune serum using a protein G column.
Antibodies were applied to the cells at 4 µg/ml.
Chemicals and reagents
Carbachol (Calbiochem), LaCl3 (Sigma), and adenosine
triphosphate sodium salt (ATP; Sigma) were prepared as
100 mM stock solutions in H2O. 1-oleoyl-2-acetyl-sn-
glycerol (OAG; Calbiochem), KT5823 (Calbiochem),
ODQ (Calbiochem), 8-bromo-cGMP (Calbiochem), and 2-
aminoethoxydiphenyl borate (2-APB; Calbiochem) solution
were prepared in DMSO. SNAP (Sigma) was prepared as a
300- or 250-mM stock dissolved in DMSO, and the
aliquots were stored at −20°C. DEA-NONOate (Cayman)
was prepared as a 100- or 30-mM stock dissolved in
ethanol or DMSO, and the aliquots were stored at −80°C.
Data analysis and presentation
Data from Ca2+-imaging were plotted as traces and
expressed as mean ± SEM of cells/wells in one experiment.
Traces from patch-clamp recording and arterial tension
measurement are representative individual experiments. Bar
charts show data in mean ± SEM of all or combined
experiments. Number of individual recordings “n” is given
in parenthesis. Student’s t test was used for statistical
comparison, with probability p<0.05 (single asterisk) or
p<0.01 (double asterisks) as a significant difference.
Results
Lack of effect of NO donors on Ca2+-influx mediated
by TRPC5
In single-cell intracellular Ca2+ measurement studies of
mTRPC5, cells were exposed to a high concentration of
SNAP (300 µM). In 18 out of 23 independent experiments,
SNAP failed to elicit a significant response (e.g., Fig. 1a).
In the other five experiments, SNAP elicited a small rise in
[Ca2+]i but this effect was not unique to the TRPC5-
expressing cells, occurring also in the vector control group
(Suppl. Fig. 2). Addition of carbachol (CCh), which acts as
an agonist at endogenous muscarinic receptors, caused
marked elevation of [Ca2+]i in TRPC5-expressing cells
(Fig. 1a) due to IP3-sensitive store Ca
2+ release and
receptor-mediated activation of TRPC5 [14]. Lanthanum
(La3+), which stabilizes the open state of TRPC5 channels
[10], enhanced the Ca2+ signal and 2-APB, which blocks
TRPC5 channels [21], suppressed the signal (Fig. 1a). In
vector-transfected cells, CCh elicited a small transient rise
in [Ca2+]i, which is due to TRPC5-independent Ca
2+-
release, and La3+ had no effect (Fig. 1b, c). Analysis of
data from all experiments indicated no significant differ-
ence between SNAP responses in TRPC5- and vector-
transfected cells (Fig. 1c). The data suggest that mTRPC5 is
stimulated by CCh and La3+ but not by SNAP.
Multiwell intracellular Ca2+ measurement studies of
hTRPC5 revealed similar insensitivity to SNAP, with
100 μM SNAP eliciting no rise in [Ca2+]i. High concen-
trations of SNAP (250 or 500 μM) elicited a [Ca2+]i rise in
some batches of hTRPC5-expressing cells but these concen-
trations also had effects in control cells (Fig. 1d, e).
Comprehensive presentation of all individual data sets is
shown in Suppl. Fig. 3, indicating that there was modest
hTRPC5 stimulation by 250 or 500 μM SNAP in some
recordings. However, statistical analysis of all data did not
support a conclusion that hTRPC5 could be stimulated by
any SNAP concentration (1–500 μM) on a reliable basis
(Fig. 1f). Strong [Ca2+]i responses on addition of the
lanthanide gadolinium (Gd3+) confirmed that there was
functional expression of TRPC5 in Tet+ but not Tet−
(control) cells (Fig. 1d–f). Concentration–response data for
Gd3+ established that the recording technique conferred the
expected sensitivity (data not shown).
A chemically distinct NO donor, DEA-NONOate, was
also tested using the single-cell (mTRPC5) and multiwell
(hTRPC5) Ca2+ measurement systems. DEA-NONOate, at a
range of concentrations from 10 to 100 µM, failed to elicit
[Ca2+]i rise in mTRPC5-expressing cells (Fig. 2a, c).
Similarly, 1 to 150 μM DEA-NONOate elicited no response
in cells expressing hTRPC5 and responding to Gd3+
(Fig. 2b, c). Preincubation with 10–100 μM DEA-
NONOate did not affect Gd3+ responses (Fig. 2d).
Lack of effect on ionic current mediated by TRPC5
Whole-cell currents were measured from hTRPC5-
expressing HEK293 (Tet+) cells using a voltage-ramp
protocol (Fig. 3). Spontaneously active TRPC5-mediated
currents occurred, as shown by the example time-series
relationship for +80 and −80 mV (Fig. 3a) and current–
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voltage relationship (I–V; Fig. 3b), which is typical of
TRPC5 [14, 23, 25]. Bath application of 150 μM DEA-
NONOate failed to stimulate or inhibit the current
(Fig. 3a, b). In contrast, the reducing agents dithiothreitol
or reduced thioredoxin elicited characteristic TRPC5
currents (Fig. 3a–d), as reported previously [23]. Neither
DEA-NONOate nor SNAP had significant effects on the
TRPC5 currents (Fig. 3d). The data further suggest that
TRPC5 is resistant to NO.
Effectiveness of NO donors to deliver NO in experiments
As positive controls for the NO donors, we first performed
isometric contraction studies on mouse aortic segments where
NO donors are known to act as potent vasorelaxants [9].
SNAP elicited relaxation of tone at 0.1–1 μM concentrations,
while DEA-NONOate elicited relaxations at 10 and 100 μM
concentrations (Fig. 4a, b). Treatment of HEK293 cells with
these two NO donors also caused substantial elevation of
intracellular NO as monitored by the NO-sensitive fluores-
cence dye DAF-FM acetate (Fig. 4c–f). As shown, extracel-
lular application of 100 μM SNAP (Fig. 4c, e) or 90 μM
DEA-NONOate (Fig. 4d, f) increased the intracellular NO
level in a time-dependent manner. We also tested the
biological activity of SNAP and DEA-NONOate through
their expected inhibitory effects on TRPC6. TRPC6 and
TRPC3 are two TRPC isoforms that were previously
reported to be inhibited by NO-cGMP-PKG pathway [12,
18]. Application of the TRPC6 activator OAG induced a
[Ca2+]i rise in TRPC6-expressing HEK293 cells (Fig. 4g).
This [Ca2+]i rise was attenuated by a PKG activator 8-bromo-
cGMP and enhanced by a PKG inhibitor KT5823 or
ODQ, a guanylate cyclase inhibitor (Fig. 4h). Importantly,
300 μM SNAP or 100 μM DEA-NONOate attenuated the
OAG-induced [Ca2+]i rise in these cells (Fig. 4g, h). The
inhibitory effect of DEA-NONOate was reversed by KT5823
(Fig. 4g, h). These results confirmed that SNAP and DEA-
NONOate applied in our systems could effectively release
NO to inhibit TRPC6 via NO-cGMP-PKG pathway [12, 18].
Collectively, these experiments demonstrate that the NO
donors used in our experiments were able to efficiently
deliver biologically active NO.
Fig. 1 SNAP on TRPC5-dependent Ca2+-entry in HEK293 cells. a–c
mTRPC5 single-cell Ca2+ data. a, b Representative time-series graphs
for [Ca2+]i in vector-transfected (b) and mTRPC5-transfected HEK293
cells (a). The bath solution contained NPSS. Arrows indicate the time
points when chemicals were added (SNAP, 300 µM; carbachol
100 µM; LaCl3 100 µM; 2-APB, 75 µM). Each trace represents the
mean ± SEM for ≥20 cells. c Mean ± SEM data for the [Ca2+]i
response 1 min after application of CCh or the maximal [Ca2+]i
response to La3+ and SNAP, as illustrated in a and b. Each bar
represents the mean value from seven independent experiments. d–f
hTRPC5 multiwell Ca2+ data. Shown are representative time-series
graphs for [Ca2+]i in response to SNAP (100 µM, 500 µM), DMSO
(0.2%), and Gd3+ (100 µM) in HEK293 cells stably expressing
hTRPC5 under a tetracycline-inducible promoter with (Tet+; d) and
without tetracycline (Tet−; e) induction. The data points represent the
mean for ≥3 wells (SEM bars have been omitted for clarity; for full
data sets see Suppl. Fig. 3). fMean ± SEM (n=3) data for the maximal
[Ca2+]i change evoked by the applied chemicals
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Inhibition of Ca2+-entry in endothelial cells (BAECs)
Resistance of TRPC5 to NO in our experiments but
sensitivity in studies of other investigators [24] may have
arisen because NO does not act directly but requires an
intermediate protein that is inadequately expressed in our
HEK293 cells relative to TRPC5. The identity of such an
intermediate is unknown and so we sought to address the
possibility by studying an endogenous Ca2+-entry signal
that involves TRPC5. The previous reports suggested that
TRPC5 is expressed in BAECs and is functionally
important in agonist-stimulated Ca2+-entry and spontaneous
Fig. 2 DEA-NONOate on
TRPC5-dependent Ca2+-entry.
a, b Representative time-series
graphs for [Ca2+]i in mTRPC5-
expressing HEK293 cells in
response to DEA-NONOate
(100 μM) (a the data points
represents the mean ± SEM for
≥20 cells in single-cell Ca2+
measurement, final vehicle con-
centration of 0.1% DMSO) and
in hTRPC5-expressing HEK293
cells (b the data points represent
the mean ± SEM for ≥3 wells in
multiwell Ca2+ measurement). c
Mean ± SEM (n≥3) data for
the maximal [Ca2+]i change in
response to DEA-NONOate as
in a (n=8) and b (n=3). d
Representative time-series
graphs for [Ca2+]i in hTRPC5-
expressing HEK293 cells in
response to Gd3+ after DEA-
NONOate. Carbachol (CCh),
100 µM; LaCl3 (La
3+), 100 µM;
GdCl3 (Gd
3+), 100 µM; and DEA-
NONOate (DEA), as indicated
(μM); 1% DMSO in b and d
Fig. 3 Ionic current through
TRPC5 channels during whole-
cell voltage clamp. Recordings
were from HEK293 cells express-
ing hTRPC5. a Representative
time course of whole-cell current
sampled at +80 mV and −80 mV
during a voltage ramp and show-
ing bath application of 150 µM
DEA-NONOate and 10 mM DTT.
b, c Current–voltage relationships
(I–Vs) for the experiment in a
showing the initial (basal) current
and the current in the presence of
DEA-NONOate (b), and the
current in the presence of DEA-
NONOate and the current induced
by DTT (c). d Mean change (▵)in inward current at −80 mV after
application of 150 µM DEA-
NONOate, 10 mM DTT, 500 µM
SNAP (10 min) or 4 µg/ml rTRX
(5 min; n≥3)
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Ca2+-entry in these cells [20, 24]. Figure 5a showed that
TRPC5 immunoreactive signals could be detected in
PECAM-1 (an endothelial cell marker)-positive BAECs.
Many research groups have investigated the effect of NO
on endothelial cell [Ca2+]i signaling, While most reports
showed an inhibitory action of NO on [Ca2+]i in endothelial
cells [5, 11, 18, 21], there were also a few reports showing
stimulatory action of NO donor SNAP on [Ca2+]i in
endothelial cells [13, 24]. In our studies, direct application
of 10 and 300 μM SNAP to cultured BAECs did not cause
significant change in [Ca2+]i level (n=4).
We then used a TRPC5-specific blocking antibody T5E3
[22] to investigate the TRPC5 component in the agonist-
stimulated Ca2+-entry and spontaneous Ca2+-entry. Effec-
tiveness of T5E3 as an inhibitor of TRPC5 was confirmed
in HEK293 cells over-expressing mTRPC5 (Fig. 5b and
Suppl. Fig. 4). T5E3 inhibited the La3+ and carbachol-
stimulated Ca2+ influx in these cells (Fig. 5b and Suppl.
Fig. 4). Specificity of T5E3 was shown through lack of
effect of T5E3 on OAG-stimulated [Ca2+]i rises in HEK293
cells over-expressing TRPC3 (Fig. 5c and Suppl. Fig. 4).
ATP stimulates TRPC5 activity via a receptor-operated
pathway in BAECs and other cell types [1, 24]. We exposed
the BAECs to anti-TRPC5 blocking antibody, T5E3, or its
control preimmune antibody (Fig. 5d–f). T5E3 suppressed
the ATP-stimulated Ca2+-entry (Fig. 5d–f) and ATP-
stimulated whole-cell current (Suppl. Fig. 6), consistent with
TRPC5 having a role in the response. The NO donor SNAP
Fig. 4 Validation of NO-releasing capacities of SNAP and DEA-
NONOate. a, b Representative time courses of isometric tension in
isolated mouse aortic segments in response to cumulatively increasing
concentrations of SNAP (a) and DEA-NONOate (b) applied to the
bath. The vessels were denuded of the endothelial layer and
preconstricted with 10 μM phenylephrine (Phe; n=4). c, d Represen-
tative time-series graphs for change of DAF-FM fluorescence (ΔF*)
in HEK293 cells in response to SNAP (100 μM, c) or DEA-NONOate
(90 μM, d). Also shown are responses to vehicle (DMSO, 0.2% in c;
DMSO, 1.5% in d). Each data point represents mean ± SEM for
measurements from four wells of a 96-well plate. e, f For three
independent experiments, mean ± SEM data for the maximal ΔF* in
response to SNAP (e) or DEA-NONOate (f) as in c and d. g
Representative time-series traces (n≥6) for [Ca2+]i in response to
100 μM OAG in HEK293 cells cotransfected with PKG1α and
mTRPC6. Prior to OAG addition, cells were pretreated for 5 min with
0.1% DMSO, 300 μM SNAP, 100 μM DEA-NONOate (DEA), or
100 μM DEA-NONOate plus 1 μM KT5823 (DEA+KT5823). The
data points represent the mean ± SEM for ≥20 cells in a single
experiment. h Summary of data showing maximal [Ca2+]i response
(Fmax/F0) to OAG (100 μM) challenge under different pretreatments
for 5 min. DMSO, 0.1%; KT5823, 1 μM; ODQ, 50 μM; 8-bromo-
cGMP, 2 mM; SNAP, 300 μM; and DEA-NONOate (DEA), 100 μM.
Mean ± SEM (n≥6 experiments)
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was tested against the Ca2+-entry and was found to be
inhibitory (Fig. 5d–f). Furthermore, in T5E3-treated cells,
SNAP generated no further inhibition (column 2 and 4 in
Fig. 5f); in addition, T5E3 had no further inhibition in the
presence of SNAP (column 3 and 4 in Fig. 5f), suggesting
that SNAP and T5E3 inhibited the same component.
To study spontaneous Ca2+-entry in BAECs, we first
exposed the BAECs to Ca2+-free physiological medium, and
then reintroduced 2 mM extracellular Ca2+. Ca2+-entry was
observed (Fig. 6a, c). This Ca2+-entry was again suppressed
by T5E3 and SNAP (Fig. 6a–c). We also used a dominant-
negative TRPC5 construct (DN-T5) that can disrupt TRPC5
function [17]. Expression of DN-T5 also reduced the
spontaneous Ca2+-entry in BAECs (Fig. 6d–f), supporting
involvement of channels that can incorporate TRPC5.
Moreover, SNAP inhibited the same component as T5E3
and DN-T5 did (Fig. 6c, f). Taken together, the data suggest
that an endogenous Ca2+-entry mechanism involving TRPC5
in endothelial cells is sensitive to inhibition by NO.
Discussion
In the present study, we found that NO donors fail to
modulate activity of mTRPC5 or hTRPC5 channels
exogenously expressed in HEK293 cells when applied at
Fig. 5 Endogenous TRPC5 expression in BAECs and inhibitory
effect of SNAP on ATP-stimulated Ca2+-entry involving TRPC5. a
Immunocytochemical detection of TRPC5 in BAECs. The cells were
stained with primary antibodies targeted to TRPC5 (TRPC5; green
signals) and to platelet endothelial cell adhesion molecule 1
(PECAM1; red signals). Also shown were the merged fluorescent
signals overlaid on the bright-view image (Merged). The control
image was the merged image from sample with the omission of
primary antibodies (Control). b Inhibitory effect of T5E3 on LaCl3
(La3+, 100 µM) and carbachol (CCh, 100 µM)-induced [Ca2+]i rises in
mTRPC5-over-expressing HEK293 cells with or without 4 µg/ml anti-
TRPC5 blocking antibody (T5E3) in the bath solution. Mean ± SEM
(n=3) data are shown (*p<0.05). Representative experimental traces
are given in Supplementary Fig. 4. c OAG (100 µM)-induced [Ca2+]i
rises in TRPC3-over-expressing HEK293 cells with 4 µg/ml preim-
mune IgG or T5E3 in the bath solution. Mean ± SEM (n=3) data are
shown (*p<0.05). Representative experimental traces are given in
Supplementary Fig. 4. d, e Representative time courses of [Ca2+]i
changes in BAECs in response to ATP (100 µM). BAECs were bathed
in HBS containing 4 µg/ml T5E3 (upper trace of e) or preimmune
IgG (d, lower trace of e) for 20–30 min at room temperature prior to
Ca2+ imaging. Bath solution was changed to HBS-EGTA containing
preimmune IgG or T5E3 at the beginning of each recording. 300 µM
SNAP (lower trace of e) or 0.1% DMSO (d, upper trace of e) was
added to the bath, followed by addition of ATP to elicit store-release.
After ATP-addition (8 min), the Ca2+ influx was initiated by changing
the bath solution to HBS containing ATP, DMSO/SNAP with T5E3/
preimmune IgG. Each trace represents the mean ± SEM of ≥10 cells
in one representative experiment. f Summary of data for all
independent experiments of the type shown in d and e, showing the
maximal [Ca2+]i change after restoring Ca
2+ in bath (n=6–10;
**p<0.01)
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concentrations that are sufficient for generation of NO, evoke
vascular relaxation, or suppress TRPC6 via protein kinase G.
We did, however, find an inhibitory effect on an endothelial
Ca2+-entry mechanism that involved TRPC5. The data
suggest that NO is not a direct modulator of TRPC5 but
that it can negatively modulate endogenous TRPC5-
containing channels through an indirect mechanism.
We occasionally observed a stimulatory effect of SNAP
that appeared greater than the response in control cells
(Fig. 1f, Suppl. Fig. 3). Although these latter results did not
achieve statistical significance, underlying examples
(Suppl. Fig. 3) are reminiscent of the results of Yoshida et
al. [24]. Therefore, we believe that TRPC5 may be
stimulated by SNAP under some conditions but we suggest
that any such effect is not due to an action of nitric oxide
and occurs only at higher concentrations of SNAP than are
necessary to evoke nitric oxide-dependent effects. High
concentrations of SNAP may generate free radicals [19],
which Yoshida et al. [24] also suggested activate TRPC5.
We did not observe any effects of DEA-NONOate.
One concern might be the stability of NO donors. The
question is whether SNAP and DEA-NONOate applied to
the cells could indeed increase NO concentration in
cultured cells. In this regard, strict protocols were followed
to preserve the activity of the NO donors. The same NO
donor preparations relaxed aortic strips concentration-
dependently, elicited NO rises in HEK293 cells, and
inhibited TRPC6 via a cGMP-PKG pathway (Fig. 4). The
data substantiate the competence of the NO donors in our
experimental settings.
The data in our study further support the conclusion that
the cysteine residues in the ion pore region of TRPC5
(cysteines 553 and 558) are involved in an extracellular
disulfide bridge [23]. Such covalent bonding precludes
availability of the cysteine residues for S-nitrosylation
unless the bridge is broken by a reducing agent. Consistent
with this conclusion, mutating the cysteines resulted in fully
active channels that were unresponsive to lanthanide [23].
The observed inhibitory effect on an endothelial Ca2+-
entry mechanism suggests the possibility for an effect of
Fig. 6 Inhibitory effect of SNAP on spontaneous Ca2+-entry
involving TRPC5 in BAECs. a, b, d, e Representative time courses
of [Ca2+]i changes in BAECs in response to extracellular Ca
2+
readdition. a, b Cells were incubated in HBS containing 4 µg/ml
T5E3 (upper trace of b) or preimmune IgG (a, lower trace of b) for
20–30 min prior to Ca2+ imaging. d, e Cells were transfected with
empty expression vector (vector) or DN-T5 construct (DN-T5).
300 µM SNAP (lower trace of b and e) or 0.1% DMSO (a and d,
upper trace of b and e) was added to the bath for 15 min, followed by
changing the bath solution to HBS DMSO/SNAP with T5E3/
preimmune IgG. Each trace represents the mean ± SEM of ≥5 cells
in one representative experiment. c, f Summary of data for all
independent experiments of the type shown in a, b (c), d, e (f),
showing the maximal [Ca2+]i change after restoring Ca
2+ in bath.
Mean ± SEM (n=4 for c; n=5–10 for f) data are shown (*p<0.05;
**p<0.01)
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NO on a Ca2+ channel complex involving TRPC5. Such an
inhibitory effect may have physiological importance as a
negative feedback mechanism in the control of NO release.
However, failure to observe stimulation or inhibition of over-
expressed TRPC5 by NO suggests that the endothelial effect
did not occur through a direct action of NO on TRPC5.
Our results in TRPC5-over-expressing HEK293 cells
and BAECs show some divergence from those of Yoshida
et al. and others [13, 24]. In additional experiments, we
used the same composition of extracellular solution and
TRPC5 clone as Yoshida et al. [24] but were unable to
observe a stimulatory effect (Suppl. Fig. 5). The reason for
the discrepancy in results is not clear. Possible complicating
factors could include differences in HEK293 cell sources,
BAEC isolation procedures, and cell culture conditions.
Such factors may alter the expression or activity of certain
cellular factors that may be required for an indirect action
of SNAP. Another possibility is that a stimulating effect of
SNAP on basal [Ca2+]i of some HEK293 cells might
enhance TRPC5 activity via Ca2+-dependent potentiation.
In summary, the study provides evidence against NO as
a direct modulator of TRPC5 channels and against S-
nitrosylation as a mechanism for stimulation of TRPC5
channels in the absence of a reducing factor. The study
does, however, suggest that NO may indirectly inhibit
endogenous Ca2+-entry mechanisms involving TRPC5.
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